Welcome to our dedicated page for BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund news (Ticker: xalcx), a resource for investors and traders seeking the latest updates and insights on BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund stock.
Track essential updates for BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. (XALCX), a closed-end fund specializing in non-investment-grade debt securities. This comprehensive resource aggregates official announcements, strategic developments, and market-related updates for investors monitoring the fund's progress toward its 2024 termination date.
Access curated information about portfolio adjustments, income distributions, and credit market positioning. Our centralized repository helps stakeholders analyze the fund's performance in global credit markets while maintaining awareness of risk management practices and capital appreciation strategies.
Key updates include earnings reports, dividend declarations, and material changes to investment approaches. Bookmark this page for convenient access to verified information supporting informed decisions about this time-bound income-focused investment vehicle.
BNY Mellon Alcentra Global Credit Funds announce a significant change in control of their sub-adviser, Alcentra NY, LLC, with BNY Mellon set to sell its interest to Franklin Templeton. This transition, expected to finalize in Q4 2022, will involve the automatic termination of current sub-advisory agreements and require the approval of new agreements by the Funds' Board and shareholders. Notably, there will be no increase in advisory fees as a result of this transaction, maintaining the current fee structure. This change aims to ensure uninterrupted service for the Funds.
